| 108428 |
ONCOLOGY REPORTS |
Absence of RKIP expression is an independent prognostic biomarker for gastric cancer patients. |
2012-12-10 |
10.3892/or.2012.2179 |
MARTINHO OLGA, SIMÕES KLEBER, LONGATTO-FILHO ADHEMAR, JACOB CARLOS EDUARDO, ZILBERSTEIN BRUNO, BRESCIANI CLÁUDIO, GAMA-RODRIGUES JOAQUIM, CECCONELLO IVAN, ALVES VENÂNCIO, REIS RUI MANUEL |
| 108427 |
ONCOLOGY LETTERS |
The expression of phospholipase A2 group X is inversely associated with metastasis in colorectal cancer. |
2012-12-10 |
10.3892/ol.2012.1067 |
HIYOSHI MASAYA, KITAYAMA JOJI, KAZAMA SHINSUKE, TAKETOMI YOSHITAKA, MURAKAMI MAKOTO, TSUNO NELSON H., HONGO KUMIKO, KANEKO MANABU, SUNAMI EIJI, WATANABE TOSHIAKI |
| 108426 |
ONCOLOGY REPORTS |
Increased expression of placental growth factor in high-grade endometrial carcinoma |
2012-12-10 |
10.3892/or.2012.2178 |
COENEGRACHTS LIEVE, SCHRAUWEN STEFANIE, VAN BREE RITA, DESPIERRE EVELYN, LUYTEN CATHERINE, JONCKX BART, STASSEN JEAN MARIE, VERGOTE IGNACE, AMANT FRÉDÉRIC |
| 108425 |
ONCOLOGY REPORTS |
Cancer-associated fibroblasts do not respond to combined irradiation and kinase inhibitor treatment. |
2012-12-10 |
10.3892/or.2012.2180 |
AFFOLTER ANNETTE, SCHMIDTMANN IRENE, MANN WOLF J., BRIEGER JÜRGEN |
| 108424 |
ONCOLOGY REPORTS |
Overexpression of Yes-associated protein confers doxorubicin resistance in hepatocellullar carcinoma. |
2012-12-10 |
10.3892/or.2012.2176 |
HUO XINYING, ZHANG QI, LIU ANGELA M., TANG CUIJU, GONG YONGLING, BIAN JIANMIN, LUK JOHN M., XU ZHI, CHEN JINFEI |
| 108423 |
ONCOLOGY REPORTS |
Visfatin affects redox adaptative responses and proliferation in Me45 human malignant melanoma cells: an in vitro study. |
2012-12-10 |
10.3892/or.2012.2175 |
BUŁDAK RAFAŁ JAKUB, BUŁDAK ŁUKASZ, POLANIAK RENATA, KUKLA MICHAŁ, BIRKNER EWA, KUBINA ROBERT, KABAŁA-DZIK AGATA, DUŁAWA-BUŁDAK ANNA, ŻWIRSKA-KORCZALA KRYSTYNA |
| 108422 |
ONCOLOGY REPORTS |
Novel cis-restricted β-lactam combretastatin A-4 analogues display anti-vascular and anti-metastatic properties in vitro. |
2012-12-10 |
10.3892/or.2012.2181 |
NATHWANI SEEMA-MARIA, HUGHES LINDA, GREENE LISA M., CARR MIRIAM, O’BOYLE NIAMH M., McDONNELL SUSAN, MEEGAN MARY J., ZISTERER DANIELA M. |
| 108421 |
ONCOLOGY LETTERS |
Dasatinib inhibits primary melanoma cell proliferation through morphology-dependent disruption of Src-ERK signaling. |
2012-12-10 |
10.3892/ol.2012.1066 |
WU JIANGHONG, LIAO XIN, YU BO, SU BING |
| 108420 |
ONCOLOGY REPORTS |
Factors predicting the response to oral fluoropyrimidine drugs: a phase II trial on the individualization of postoperative adjuvant chemotherapy using oral fluorinated pyrimidines in stage III colorectal cancer treated by curative resection (ACT-01 Study) |
2012-12-10 |
10.3892/or.2012.2177 |
MORI TAKEO, OHUE MASAYUKI, TAKII YASUMASA, HASHIZUME TADASHI, KATO TOMOYUKI, KOTAKE KENJIRO, SATO TOSHIHIKO, TANGO TOSHIRO |
| 108419 |
ONCOLOGY REPORTS |
High expression of microRNA-200c predicts poor clinical outcome in diffuse large B-cell lymphoma. |
2012-12-10 |
10.3892/or.2012.2173 |
BERGLUND MATTIAS, HEDSTRÖM GUSTAV, AMINI ROSE-MARIE, ENBLAD GUNILLA, THUNBERG ULF |
